MENOVO
LIVE

Serial Number

79213966

Owner

NINGBO MENOVO PHARMACEUTICAL CO., LTD.

Filing Date

Jan 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MENOVO Trademark

Serial Number: 79213966 • Registration: 5477856

MENOVO is a trademark filed by NINGBO MENOVO PHARMACEUTICAL CO., LTD. on January 12, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NINGBO MENOVO PHARMACEUTICAL CO., LTD.

Room. 1406, Building 1
Zhejiang 315000 , CN

Entity Type: 99

Trademark Details

Filing Date

January 12, 2017

Registration Date

May 29, 2018

Published for Opposition

March 13, 2018

Cancellation Date

December 13, 2024

Goods & Services

Medicines for human purposes for antibiotics, the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer, gastrointestinal diseases and coughs; syrups for pharmaceutical purposes for the treatment of coughs; pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; chemico-pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; analgesics; drugs for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; vermicide for human or veterinary use; anthelmintics for human or veterinary use; medical pills for the relief of pain and for the treatment of headache, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; capsules for pharmaceutical purposes for the relief of allergy and pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; sedatives; biological preparations for medical purposes for antibiotics, for the prevention and treatment of infectious diseases and for the treatment of cancer; chemical preparations for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; injectable pharmaceuticals for the treatment of cancer, immunosuppression and infection; medicinal preparations for the mouth to be applied in the form of tablets for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; active pharmaceutical ingredient for the relief of pain and for the treatment of inflammation, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 19, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Feb 1, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 1, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 13, 2025 INTR
CANCELLED SECTION 71
Dec 13, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 19, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 14, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 14, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2018 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 31, 2018 TCCA
REFUSAL PROCESSED BY IB
Sep 9, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 19, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 17, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 10, 2017 REPR